• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

检测衰变加速因子(DAF,CD55)和CD59减轻补体介导的异种红细胞损伤的能力。

Test for ability of decay-accelerating factor (DAF, CD55) and CD59 to alleviate complement-mediated damage of xeno-erythrocytes.

作者信息

Miyagawa S, Shirakura R, Matsumiya G, Nakata S, Matsuda H, Hatanaka M, Matsumoto M, Kitamura H, Seya T

机构信息

First Department of Surgery, Osaka University Medical School, Japan.

出版信息

Scand J Immunol. 1993 Jul;38(1):37-44. doi: 10.1111/j.1365-3083.1993.tb01691.x.

DOI:10.1111/j.1365-3083.1993.tb01691.x
PMID:7687071
Abstract

We investigated the susceptibility to human complement (C) of xeno-erythrocytes into which phosphatidylinositol (PI)-anchored human C regulatory protein, decay-accelerating factor (DAF) or CD59 had been incorporated. Erythrocytes of sheep (Esh), swine (Esw), dog (Edg), and guinea pig (Egp), unsensitized with human natural antibody (Ab), were used as xeno-target. C-mediated lysis of erythrocytes (E) was induced in both classical and alternative pathways in parallel with the density of the sensitized Ab, except for Egp. The efficacy of DAF/CD59-mediated protection of the xeno E from human C, however, differed among these E species. In both classical and alternative pathways, Esh or Esw, which are non-activator surfaces, were protected by the incorporated DAF or CD59, DAF being more effective than CD59. On the other hand, CD59 was more effective than DAF in both pathways in protection of Egp, which is an alternative pathway activator. To elucidate this different behaviour of DAF and CD59, C3 step inhibition by the incorporated DAF or CD59 was measured. DAF was effective in the suppression of classical pathway-mediated C3 deposition in Esh, Esw and Egp, but not in Edg, while CD59 exhibited negligible effects in this regard. Next, inhibition of the lysis by CD59 was tested by haemolytic assay. CD59 did not block the C5b-8-mediated lysis in any xeno E. It also barely blocked C5b-9-mediated lysis, except in the case of Egp, in which CD59 partly blocked C9 attack. Membrane constituents on targets other than the incorporated complement inhibitors may be a crucial factor in the induction of cytolysis and, presumably, in hyperacute rejection.

摘要

我们研究了已掺入磷脂酰肌醇(PI)锚定的人补体(C)调节蛋白、衰变加速因子(DAF)或CD59的异种红细胞对人补体的敏感性。未被人天然抗体(Ab)致敏的绵羊(Esh)、猪(Esw)、狗(Edg)和豚鼠(Egp)的红细胞用作异种靶细胞。除Egp外,在经典途径和替代途径中,红细胞(E)的C介导裂解均与致敏Ab的密度平行诱导。然而,DAF/CD59介导的对异种E的人C保护作用在这些E物种中有所不同。在经典途径和替代途径中,作为非激活剂表面的Esh或Esw受到掺入的DAF或CD59的保护,DAF比CD59更有效。另一方面,在保护作为替代途径激活剂的Egp方面,CD59在两种途径中都比DAF更有效。为了阐明DAF和CD59的这种不同行为,测量了掺入的DAF或CD59对C3步骤的抑制作用。DAF可有效抑制经典途径介导的C3在Esh、Esw和Egp中的沉积,但对Edg无效,而CD59在这方面的作用可忽略不计。接下来,通过溶血试验测试CD59对裂解的抑制作用。CD59在任何异种E中均未阻断C5b-8介导的裂解。除了Egp的情况外,它也几乎未阻断C5b-9介导的裂解,在Egp中CD59部分阻断了C9攻击。除了掺入的补体抑制剂外,靶细胞上的膜成分可能是诱导细胞溶解以及可能是超急性排斥反应的关键因素。

相似文献

1
Test for ability of decay-accelerating factor (DAF, CD55) and CD59 to alleviate complement-mediated damage of xeno-erythrocytes.检测衰变加速因子(DAF,CD55)和CD59减轻补体介导的异种红细胞损伤的能力。
Scand J Immunol. 1993 Jul;38(1):37-44. doi: 10.1111/j.1365-3083.1993.tb01691.x.
2
Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.Crry,而非CD59和衰变加速因子(DAF),对于小鼠红细胞在体内免受自发补体攻击至关重要。
Blood. 2002 May 15;99(10):3707-16. doi: 10.1182/blood.v99.10.3707.
3
Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor.抗生物素蛋白-生物素处理的人红细胞对补体敏感性增强是补体调节因子CD59和衰变加速因子被中和的结果。
Biochem J. 1995 May 1;307 ( Pt 3)(Pt 3):651-6. doi: 10.1042/bj3070651.
4
Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.通过人CD59和/或衰变加速因子的表达保护大鼠内皮细胞免受灵长类补体介导的溶解。
Transplantation. 1994 Dec 15;58(11):1222-9.
5
Two modes of homologous C3 deposition on Ramos Burkitt's lymphoma cell substrains co-expressing DAF (CD55), CD59, and CR2 (CD21), and on cells lacking them.同源C3在共表达衰变加速因子(CD55)、CD59和补体受体2(CD21)的Ramos伯基特淋巴瘤细胞亚株以及缺乏这些分子的细胞上沉积的两种模式。
Int Immunol. 1992 Dec;4(12):1361-71. doi: 10.1093/intimm/4.12.1361.
6
C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.人补体对猪内皮细胞的C5b-8级联溶解作用及转染CD59的功能特性
Scand J Immunol. 1996 Apr;43(4):361-6. doi: 10.1046/j.1365-3083.1996.d01-50.x.
7
Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation.通过衰变加速因子(DAF)和CD59预防异种移植中超急性排斥反应的可能性。
Transplant Proc. 1994 Jun;26(3):1235-8.
8
Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.人肺癌细胞系表达细胞膜补体抑制蛋白,对补体介导的细胞溶解具有极强的抗性;体外与人正常呼吸道上皮的比较及抗性机制的探究。
Clin Exp Immunol. 1998 Aug;113(2):173-82. doi: 10.1046/j.1365-2249.1998.00581.x.
9
Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting.基因靶向揭示衰变加速因子在调节红细胞表面补体激活中的作用。
Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):628-33. doi: 10.1073/pnas.96.2.628.
10
Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.替代补体途径介导的髓样细胞细胞毒性:参与C3沉积和细胞溶解调节的膜因子库。
Eur J Immunol. 1991 Aug;21(8):1787-92. doi: 10.1002/eji.1830210802.

引用本文的文献

1
Antibody-independent classical complement pathway activation and homologous C3 deposition in xeroderma pigmentosum cell lines.色素沉着性干皮病细胞系中不依赖抗体的经典补体途径激活及同源C3沉积
Clin Exp Immunol. 1999 Jun;116(3):547-53. doi: 10.1046/j.1365-2249.1999.00923.x.
2
Complementary recognition of alternative pathway activators by decay-accelerating factor and factor H.衰变加速因子和H因子对替代途径激活剂的互补识别
Infect Immun. 1998 Feb;66(2):399-405. doi: 10.1128/IAI.66.2.399-405.1998.